Byrd, Kenneth, and Phu Truong. 2014. “Bortezomib in the Treatment of Acquired Von Willebrand Disease Secondary to Monoclonal Gammopathy of Undetermined Significance”. Kansas Journal of Medicine 7 (4): 167-70. https://doi.org/10.17161/kjm.v7i4.11507.